not losing weight on semaglutide should i switch to tirzepatide vs. for Loss Switching from Semaglutide to Tirzepatide:

However, multiple customers report difficulty with the cancellation process

It just does it by fixing the hormonal environment that was preventing fat loss in the first place, rather than attacking fat cells directly

Recent Major Changes Indications and Usage for Zepbound ZEPBOUND is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated in combination with a reduced-calorie diet and increased physical activity: to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition

Adems, sostuvo que no se han demostrado efectos graves, como arritmias o alteraciones cardacas significativas, con su uso

You can always reach out if you need guidance or support